David Shaw’s Mural Oncology MURA Stock Holding History

David Shaw’s Portfolio MURA Stock Details MURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-28,427	Closed	-$168K	–	4596
2023 Q4	$168K	Buy	+28,427	New	+$114K	﹤0.01%	3910

Other funds holding MURA

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

SCM

Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return

AFA

Alta Fundamental Advisers New York $333M AUM 102.25% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David Shaw's MURA Position: Q1 2024 in Review

David Shaw sold out of Mural Oncology (MURA) in Q1 2024, closing a stake of 28,427 shares — an estimated $168K sold.

David Shaw first reported a position in MURA in Q4 2023 and held it in 1 quarter. The position peaked at $168K in Q4 2023. 101 funds tracked by Wall St. Rank hold MURA as of Q1 2024.

David Shaw reported no remaining Mural Oncology position as of Q1 2024 after selling out during the quarter.
David Shaw sold 28,427 Mural Oncology shares in Q1 2024, an estimated $168K.
David Shaw first reported a position in Mural Oncology in Q4 2023 and held it in 1 quarter.
David Shaw's Mural Oncology position peaked at $168K in Q4 2023.
101 funds tracked by Wall St. Rank held Mural Oncology as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.